News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics.
The agreement brings together Biognosys' Spectronaut Pulsar DIA software and Waters' SONAR data-independent acquisition mass spectrometry method.
The full analysis has yet to be completed, but initial findings from the breast cancer study appear positive as researchers begin enrolling for a third trial.
The scientists hope to incorporate the method, which can measure endogenous peptides at zeptomolar concentrations, in clinical trials starting next year.
Additional studies and reanalyses can reclassify variants of unknown significance, speakers at the National Society of Genetic Counselors meeting said.
The study, which looked at 41 breast cancer cell lines, suggests that such an approach could enable higher-throughput protein-protein interaction work.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.
This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.